These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2830821)

  • 1. Proto-oncogene fos: factors affecting expression and covalent modification of the gene product.
    Barber JR; Sassone-Corsi P; Verma IM
    Ann N Y Acad Sci; 1987; 511():117-30. PubMed ID: 2830821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proto-oncogene fos expression and post-translational modification.
    Barber JR; Sassone-Corsi P; Verma IM
    Prog Clin Biol Res; 1988; 266():23-37. PubMed ID: 3132724
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum.
    Barber JR; Verma IM
    Mol Cell Biol; 1987 Jun; 7(6):2201-11. PubMed ID: 3110603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and viral fos genes: structure, regulation of expression and biological properties of their encoded products.
    Müller R
    Biochim Biophys Acta; 1986; 823(3):207-25. PubMed ID: 3011086
    [No Abstract]   [Full Text] [Related]  

  • 5. Proto-oncogene fos: an inducible multifaceted gene.
    Mitchell RL; Hanks SK; Verma IM
    Symp Fundam Cancer Res; 1986; 39():99-113. PubMed ID: 2827284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C.
    Mahadevan LC; Wills AJ; Hirst EA; Rathjen PD; Heath JK
    Oncogene; 1990 Mar; 5(3):327-35. PubMed ID: 2107492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proto-oncogene fos: an inducible gene.
    Verma IM; Mitchell RL; Sassone-Corsi P
    Princess Takamatsu Symp; 1986; 17():279-90. PubMed ID: 3332016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
    Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
    Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters.
    Schönthal A; Herrlich P; Rahmsdorf HJ; Ponta H
    Cell; 1988 Jul; 54(3):325-34. PubMed ID: 2840203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
    Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of c-fos gene transcription by negative and positive cellular factors.
    Sassone-Corsi P; Verma IM
    Nature; 1987 Apr 2-8; 326(6112):507-10. PubMed ID: 3561489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity.
    Morrison DK; Kaplan DR; Rapp U; Roberts TM
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8855-9. PubMed ID: 3057494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-fos expression induces bone tumors in transgenic mice.
    Rüther U; Komitowski D; Schubert FR; Wagner EF
    Oncogene; 1989 Jul; 4(7):861-5. PubMed ID: 2547184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1 stimulates DNA synthesis and anchorage-independent growth of Rat-1 fibroblasts through a protein kinase C-dependent mechanism.
    Muldoon LL; Pribnow D; Rodland KD; Magun BE
    Cell Regul; 1990 Mar; 1(4):379-90. PubMed ID: 2129223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a phorbol ester-repressible v-src-inducible gene.
    Simmons DL; Levy DB; Yannoni Y; Erikson RL
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1178-82. PubMed ID: 2537491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock induces the transcriptional activation of c-fos protooncogene.
    Colotta F; Polentarutti N; Staffico M; Fincato G; Mantovani A
    Biochem Biophys Res Commun; 1990 May; 168(3):1013-9. PubMed ID: 2111988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells.
    de Groot RP; Schoorlemmer J; van Genesen ST; Kruijer W
    Nucleic Acids Res; 1990 Jun; 18(11):3195-202. PubMed ID: 2113273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.